Trial Profile
Placebo-controlled trial of risperidone augmentation for SSRI [selective serotonin reuptake inhibitor]-resistant civilian PTSD [post-traumatic stress disorder]
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Risperidone (Primary) ; Sertraline
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- 09 Jan 2007 Status change
- 02 Sep 2006 New trial record.